AAV5-CD39/CD73 (Arthrogen)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV5-CD39/CD73 (Arthrogen)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of Action5'-nucleotidase stimulantsEctonucleoside triphosphate diphosphohydrolase 1 agonists

Targets5'-nucleotidaseEctonucleoside triphosphate diphosphohydrolase 1

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArthrogen

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesArthrogen

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

ATC CodeN/A